"Polysorbates" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Sorbitan mono-9-octadecanoate poly(oxy-1,2-ethanediyl) derivatives; complex mixtures of polyoxyethylene ethers used as emulsifiers or dispersing agents in pharmaceuticals.
| Descriptor ID |
D011136
|
| MeSH Number(s) |
D02.033.455.250.700.690 D05.750.741.700 D25.720.741.700 J01.637.051.720.741.700
|
| Concept/Terms |
Polysorbates- Polysorbates
- PSML
- Polyoxyethylene Sorbitan Monolaurate
- Monolaurate, Polyoxyethylene Sorbitan
- Sorbitan Monolaurate, Polyoxyethylene
|
Below are MeSH descriptors whose meaning is more general than "Polysorbates".
Below are MeSH descriptors whose meaning is more specific than "Polysorbates".
This graph shows the total number of publications written about "Polysorbates" by people in this website by year, and whether "Polysorbates" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2006 | 1 | 0 | 1 |
| 2008 | 1 | 1 | 2 |
| 2009 | 1 | 1 | 2 |
| 2010 | 1 | 0 | 1 |
| 2020 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Polysorbates" by people in Profiles.
-
Lederer K, Castaño D, Gómez Atria D, Oguin TH, Wang S, Manzoni TB, Muramatsu H, Hogan MJ, Amanat F, Cherubin P, Lundgreen KA, Tam YK, Fan SHY, Eisenlohr LC, Maillard I, Weissman D, Bates P, Krammer F, Sempowski GD, Pardi N, Locci M. SARS-CoV-2 mRNA Vaccines Foster Potent Antigen-Specific Germinal Center Responses Associated with Neutralizing Antibody Generation. Immunity. 2020 12 15; 53(6):1281-1295.e5.
-
Solis C, Forsberg F, Wheatley MA. Preserving enhancement in freeze-dried contrast agent ST68: Examination of excipients. Int J Pharm. 2010 Aug 30; 396(1-2):30-8.
-
Forsberg F, Liu JB, Patel M, Liu L, Lin L, Solis C, Fox TB, Wheatley MA. Preclinical acute toxicology study of surfactant-stabilized ultrasound contrast agents in adult rats. Int J Toxicol. 2010 Jan-Feb; 29(1):32-9.
-
Cushing DJ, Kowey PR, Cooper WD, Massey BW, Gralinski MR, Lipicky RJ. PM101: a cyclodextrin-based intravenous formulation of amiodarone devoid of adverse hemodynamic effects. Eur J Pharmacol. 2009 Apr 01; 607(1-3):167-72.
-
Arhin FF, Tomfohrde K, Draghi DC, Aranza M, Parr TR, Sahm DF, Moeck G. Newly defined in vitro quality control ranges for oritavancin broth microdilution testing and impact of variation in testing parameters. Diagn Microbiol Infect Dis. 2008 Sep; 62(1):92-5.
-
Arhin FF, Sarmiento I, Belley A, McKay GA, Draghi DC, Grover P, Sahm DF, Parr TR, Moeck G. Effect of polysorbate 80 on oritavancin binding to plastic surfaces: implications for susceptibility testing. Antimicrob Agents Chemother. 2008 May; 52(5):1597-603.
-
Wheatley MA, Forsberg F, Dube N, Patel M, Oeffinger BE. Surfactant-stabilized contrast agent on the nanoscale for diagnostic ultrasound imaging. Ultrasound Med Biol. 2006 Jan; 32(1):83-93.